References

Acupuncture Allergies Alzheimer's Disease Androgen Anxiety Disorders Asthma Atherosclerosis Attention Deficit Hyperactivity Disorder Bacterial Vaginosis Biofeedback Bipolar Disorder Birth Control Pills Blood Donation and Transfusion Breast Augmentation and Reduction Breast Cancer Breastfeeding Breast Reconstruction Caregiving Cervical Cancer Chiropractic Chlamydia Cholesterol Chronic Fatigue Syndrome Clinical Trials Colon Cancer Contraception Depression Diabetes Dry Eye Syndrome Eating Disorders Endometriosis Epilepsy Estrogen Fibroids Fibromyalgia Fitness Flu/Colds Gastroesophageal Reflux Disease (GERD) Genetic Testing Genital Herpes Glaucoma Gonorrhea Health Insurance Heart Disease Hepatitis High Blood Pressure HIV/AIDS Homeopathy Human Papillomavirus Hypnosis Hysterectomy Incontinence Infertility Irritable Bowel Syndrome Legal Health Tools Liposuction Lung Cancer Lupus Macular Degeneration Medication Safety Menopause Menstrual Disorders Metabolic Syndrome Migraine Multiple Sclerosis Naturopathy Nonsurgical Aesthetic Procedures Nutrition Obesity Ocular Allergies Oral Health Osteoarthritis Osteopathic Medicine Osteoporosis Ovarian Cancer Overactive Bladder Pain Management Pelvic Organ Prolapse Pelvic Pain Peripheral Arterial Disease Polycystic Ovary Syndrome Pregnancy Premenstrual Syndrome Preparing for Surgery Progesterone Rheumatoid Arthritis Schizophrenia Scleroderma Sexual Dysfunction Sinusitis Sjogren's Syndrome Skin Cancer Skin Health Sleep Disorders Smoking Stress Stroke Substance Abuse Tai Chi Teen Health Thyroid Disorders Trichomoniasis Urinary Tract Conditions Urinary Tract Infection Uterine Cancer Varicose Veins Violence Against Women Vulvodynia Weight Management Yeast Infections Yoga

"US FOOD & DRUG ADMINISTRATION (FDA) APPROVES ADDERALL XRr TO TREAT ADULTS." August 12, 2004. Shire Pharmaceuticals Group, LLC.http://www.shire.com. Accessed 9/15/04.

Weiss, Margaret, and Candice Murray. "Assessment and management of attention-deficit hyperactivity disorder in adults." Canadian Medical Association Journal. 168(6), March 18, 2003

Talen, Jamie, "High-tech tools focus on ADHD; Non-drug approaches to diagnosis and treatment draw new research," Newsday, pg. B56, June 1, 2004.

Carey, Benedict, "Focusing the mind; Interest rises in non-drug therapies for attention deficit in children, Los Angeles Times, pg. F-1, Sept. 15, 2003)

Barbaresi WJ, et al. How common is ADHD? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002 Mar;156(3):217-24.

Incidence of ADHD in Adults, PCC Visuals, November 2002.

"The ABCs of ADD." National Attention Deficit Disorder Association. Modified April 2002. http://www.add.org. Accessed Aug. 2003.

"Attention Deficit Hyperactivity Disorder (ADHD) - Questions and Answers." National Institute of Mental Health. Updated April 2003. http://www.nimh.nih.gov. Accessed Aug. 2003.

"Feeling overwhelmed, disorganized, scattered?" National Attention Deficit Disorder Association. Modified March 2002. http://www.add.org. Accessed Aug. 2003.

"ADHD Medications" American Academy of Family Physicians. Updated Dec. 2002. http://familydoctor.org. Accessed Aug. 2003.

"AD/HD in Adults - Fact Sheet #7" Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). Updated July 2001. http://www.chadd.org. Accessed Aug. 2003.

"Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV)." American Psychiatric Association. Published 1994.http://www.psychologynet.org. Accessed May 2002.

Nadeau, K. & Quinn, P. (2002). Understanding Women with AD/HD. Silver Spring, MD: Advantage Books. 888-238-8588.

Nadeau, K., Littman, E., & Quinn, P. (1999). Understanding Girls with AD/HD. Silver Spring, MD: Advantage Books. 888-238-8588.

ADDvance: A Resource for Women and Girls with ADHD. Copyright 2001. http://ADDvance.com. Accessed Aug. 2003.

"FDA In USA Approves Non Stimulant Option For Treatment of ADHD" Adders.org. Nov. 2003. http://www.adders.org. Accessed Aug. 2003.

"Strattera (Atomoxetine Hydrochloride) Capsules, Rx" CDER New and Generic Drug- Approvals: 1998-2002. http://www.fda.gov. Accessed Dec. 2002.

Barbaresi WJ, Katusic SK, Colligan RC, Pankratz VS, Weaver AL, Weber KJ, Mrazek DA, Jacobsen SJ. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002 Mar;156(3):217-24.

Incidence of ADHD in Adults, PCC Visuals, November 2002

McGuffin P, Riley B, Plomin R. 2001. Toward behavioral genomics. Science 291:1232-49

Kovatchev B, Cox D, Hill R, Reeve R, Robeva R, Loboschefski T.A psychophysiological marker of attention deficit/hyperactivity disorder (ADHD)--defining the EEG consistency index. Appl Psychophysiol Biofeedback. 2001 Jun;26(2):127-40.

Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN, Rapoport JL. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder .JAMA. 2002 Oct 9;288(14):1740-8.

Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics. 2003 Jan;111(1):97-109.

Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature. Pediatrics 2003 Jan;111(1):179-85

Wilens TE, Biederman J, Spencer TJ. Attention deficit/hyperactivity disorder across the lifespan. Annu Rev Med. 2002;53:113-31. Review.

Attention-deficit/hyperactivity disorder treatment with a once-daily formulation of methylphenidate: effect on growth and tics, European Neuropsychopharmacology 2002;12(Suppl 3):S413 (abstract) Presented at the 15th Congress of the European College of Neuropsychopharmacology, 2002 (poster)

Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002 Feb 26;58(4):527-36.

National Institutes of Health Consensus Panel on ADHD. National Institutes of Health consensus development conference statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry. 2000; 30:182-193

Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA. 2001 Jan 3;285(1):60-6.

Hankin, CS et. al., The Burden of Attention-Deficit/Hyperactivity Disorder. Drug Benefit Trends, Vol. 12, Issue 4:April 2001

Jensen, P. S., L. Kettle, et al. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities" J Am Acad Child Adolesc Psychiatry, 1999 July 38(7): 797-804.

"ADHD - Unproven Treatments" 2001 American Academy of Pediatrics. Medem Medical Library. http://www.medem.com. Accessed Aug. 2003.

"Attention Deficit and Hyperactivity Disorder." The Mayo Clinic. September 2005. http://www.mayoclinic.com. Accessed May 2006.

"Attention Deficit Disorder Articles." The Attention Deficit Disorder Association. 2006. http://www.add.org. May 2006.

"ADHD." The Centers for Disease Control and Prevention. September 2005. http://www.cdc.gov. Accessed May 2006.

Letter regarding Daytrana approval. The US Department of Health and Human Services. April 2006. http://www.fda.gov. Accessed May 2006.